IDEAS home Printed from https://ideas.repec.org/a/bjf/journl/v10y2025i10p52-59.html
   My bibliography  Save this article

In Vitro Evaluation of Hesperidin’s α-Glucosidase Inhibitory Kinetics and Its Potential Role in Type 2 Diabetes Management

Author

Listed:
  • Iji, Silas Itiwe

    (Department of Biochemistry, University of Jos, Jos, Plateu State)

  • Dearsly, Emmanuel Markus

    (Department of Biochemistry, College of Natural and Applied Sciences, Salem University, Kogi State)

  • Dada, Emmanuel Damilo

    (Department of Biochemistry, College of Natural and Applied Sciences, Salem University, Kogi State)

  • Eze, Kingsley Chijioke

    (Department of Biochemistry, Faculty of Basic Medical Sciences, University of Calabar)

  • Oshatuyi Olukayode

    (Department of Biochemistry, Faculty of Basic Medical Sciences, University of Calabar)

  • ET Akinlade

    (Department of Physiology & Biochemistry, Faculty of Basic Medical and Health Sciences, Thomas Adewumi University, Oko-Irese, Kwara State)

  • Adaji Princess Ojoma

    (Department of Physiology & Biochemistry, Faculty of Basic Medical and Health Sciences, Thomas Adewumi University, Oko-Irese, Kwara State)

  • Emmanuel Ikegima

    (Department of Biochemistry, College of Natural and Applied Sciences, Salem University, Kogi State)

Abstract

Background: Type 2 diabetes mellitus is driven in part by postprandial hyperglycemia (PPHG), for which inhibition of intestinal α-glucosidase is a validated strategy. Hesperidin, a citrus-derived flavonoid, has been reported to modulate carbohydrate metabolism, but its kinetic interaction with α-glucosidase has not been fully clarified. Objective: To characterize the inhibitory kinetics of hesperidin against Saccharomyces cerevisiae α-glucosidase and evaluate its potential as a candidate for managing PPHG. Methods: α-Glucosidase activity was assayed using p-nitrophenyl-α-D-glucopyranoside (pNPGP) in 0.1 M phosphate buffer (pH 6.8). Enzyme was pre-incubated with hesperidin (100 μM) at 37 °C for 10 min; reactions were initiated with substrate (0.125–4.000 mM), incubated for 20 min, and quenched with 100 mM Na₂CO₃. Product formation (p-nitrophenol) was monitored at 405 nm. Controls lacked inhibitor; acarbose served as a positive control. Initial velocities were fitted by Lineweaver–Burk plots to estimate kinetic parameters; the inhibition constant (K_i) was derived from secondary plots. Experiments were performed in triplicate and analyzed by linear regression. Results: Hesperidin produced concentration-dependent inhibition consistent with a competitive mechanism: double-reciprocal plots intersected on the y-axis, V_max was effectively unchanged, and K_m increased from 0.046 mM (control) to 2.511 mM (+hesperidin). The calculated K_i = 0.0019 mM indicates high affinity for the free enzyme. Acarbose exhibited the expected inhibitory profile, corroborating assay validity. Conclusions: Hesperidin is a potent competitive inhibitor of α-glucosidase in vitro, markedly reducing apparent substrate affinity without impacting maximal catalytic rate. These kinetics support hesperidin’s promise as a natural adjunct for PPHG control.

Suggested Citation

  • Iji, Silas Itiwe & Dearsly, Emmanuel Markus & Dada, Emmanuel Damilo & Eze, Kingsley Chijioke & Oshatuyi Olukayode & ET Akinlade & Adaji Princess Ojoma & Emmanuel Ikegima, 2025. "In Vitro Evaluation of Hesperidin’s α-Glucosidase Inhibitory Kinetics and Its Potential Role in Type 2 Diabetes Management," International Journal of Research and Innovation in Applied Science, International Journal of Research and Innovation in Applied Science (IJRIAS), vol. 10(10), pages 52-59, October.
  • Handle: RePEc:bjf:journl:v:10:y:2025:i:10:p:52-59
    as

    Download full text from publisher

    File URL: https://www.rsisinternational.org/journals/ijrias/uploads/vol10-iss10-pg52-59-202510_pdf.pdf
    Download Restriction: no

    File URL: https://www.rsisinternational.org/journals/ijrias/articles/in-vitro-evaluation-of-hesperidins-glucosidase-inhibitory-kinetics-and-its-potential-role-in-type-2-diabetes-management/
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjf:journl:v:10:y:2025:i:10:p:52-59. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrias/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.